An integrated approach to understanding the metabolic rewiring of cancer cells

Mark A. Keibler(Alnylam Pharmaceuticals (United States))
DSpace@MIT (Massachusetts Institute of Technology)
January 1, 2017
Cited by 0


Related Papers